DEBATE ON THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA: Part 1

ESPID Education, Susanna Esposito, 31212

DEBATE ON THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA (CAP): Part 1

ESPID Education, David Greenberg, 31213

215 years of vaccination: job done?

ESPID Education, Andrew Pollard, 31502

FUTURE VACCINES

ESPID Education, Nicola Principi, 31203

CORRELATES OF PROTECTION AND THE ROLE OF CELL MEDIATED IMMUNITY

ESPID Education, Andrew Pollard, 31204

Safety issues related to the use of adjuvants

ESPID Education, Timo Vesikari, 31205

EMA priorities in pediatric infectious diseases

ESPID Education, Paolo Rossi, 31206

ARE IMMUNOMODULATORS / IMMUNOSTIMULANTS EFFECTIVE IN CHILDEN?

ESPID Education, Urs Schaad, 31208

Update on Probiotics in neonates

ESPID Education, Paolo Manzoni, 31209

UNDERSTANDING OF MICROBIOME AND EARLY COLONISATION OF NEONATES

ESPID Education, Vytautas Usonis, 31210

DEBATE ON PROBIOTICS

ESPID Education, Valentina Fabiano, 31211

ESPID Fellowship Award 2010 Recipient Prediction of serious infections in febrile children at the emergency department: a framework for decision support

ESPID Education, Rianne Oostenbrink, 31200

ESPID Fellowship Award 2007 Recipient The influence of maternal HIV and Mycobacterium tuberculosis infection on infant responses to childhood vaccinations

ESPID Education, Christine Jones, 31196

ESPID Young Investigator Award 2013 Ceremony Chloroquine modulates fungal immune response in phagocytic cells of chronic granulomatous disease patients

ESPID Education, Stefanie Henriet, 31199

ESPID Young Investigator Award 2013 Ceremony A new approach to respiratory rate in febrile children: clinical usefulness for detecting lower respiratory tract infections

ESPID Education, Ruud Nijman, 31197

ESPID Fellowship Award 2013 Ceremony Immunology of RSV infection in children

ESPID Education, Santtu Heinonen, 31198

ESPID Fellowship Award 2013 Ceremony Analysis of the phenomenon of autoagglutination and complement resistance in Moraxella catarrhalis

ESPID Education, Sara Bernhard-Stirnemann, 31201

ANTIBODY PERSISTENCE TO PRE-SCHOOL YEARS FOLLOWING IMMUNISATION AT 2, 4 AND 12 MONTHS WITH 7-VALENT AND 13-VALENT PNEUMOCOCCAL GLYCOCONJUGATE VACCINES

ESPID Education, Johannes Trück, 31493

HBSAG QUANTITY STRONGLY CORRELATES WITH PLASMA LEVELS OF MIRNAS ABERRANTLY EXPRESSED IN HBEAG POSITIVE AND HBEAG NEGATIVE CHILDREN WITH CHB

ESPID Education, Thilde Winther, 31497

IMPACT OF 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV10) AGAINST INVASIVE PNEUMOCOCCAL DISEASE (IPD) AMONG VACCINE-ELIGIBLE CHILDREN IN FINLAND

ESPID Education, Hanna Rinta-Kokko, 31492

MAJOR REDUCTION OF ROTAVIRUS BUT NOT NOROVIRUS GASTROENTERITIS FOLLOWING UNIVERSAL IMMUNIZATION WITH ROTATEQ VACCINE IN FINLAND

ESPID Education, Maria Hemming, 31499

GENE EXPRESSION PROFILE AND CORRELATION WITH SEVERITY OF ILLNESS AMONG CHILDREN WITH ACUTE HEMATOGENOUS OSTEOMYELITIS CAUSED BY METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS

ESPID Education, Lawson Copley, 31494

THE FIRST NOROVIRUS BIVALENT GI.1/GII.4 VIRUS-LIKE PARTICLE (VLP) VACCINE IN MAN

ESPID Education, John Treanor, 31498

CLINICAL SIGNIFICANCE OF CO-INFECTIONS WITH VIRUSES AND BACTERIA

ESPID Education, Oana Falup-Pecurariu, 31190

Short and long-term complications of respiratory infections

ESPID Education, Vana Spoulou, 31191

Genome-wide studies in pediatric infectious diseases

ESPID Education, Mike Levin, 31193

Rheumatic disease in 2013

ESPID Education, Alberto Martini, 31194

LYME DISEASE

ESPID Education, Werner Zenz, 31195

Emerging respiratory viruses

ESPID Education, Albert Osterhaus, 31187

Viral infections, infectious wheezing and asthma development

ESPID Education, Sejal Saglani, 31188

Should influenza be prevented and treated?

ESPID Education, Terho Heikkinen, 31189

How vaccines prevent infections

ESPID Education, Adam Finn, 31185

AN UPDATE ON VACCINES TO PREVENT RESPIRATORY ILLNESSES IN CHILDREN

ESPID Education, Edwards Kathryn, 31186

COULD WE HAVE A UNIFIED EUROPEAN VACCINATION SCHEDULE? - RATIONALE

ESPID Education, Jacek Mrukowicz, 20842

COULD WE HAVE A UNIFIED EUROPEAN VACCINATION SCHEDULE?

ESPID Education, Pier Luigi Lopalco, 20843

CURRENT DIAGNOSIS AND TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN IN THE ERA OF PNEUMOCOCCAL VACCINATION: OLD VERSUS NEW WORLD - EUROPE

ESPID Education, Javier Diez-Domingo, 20844

CURRENT DIAGNOSIS AND TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN IN THE ERA OF PNEUMOCOCCAL VACCINATION: OLD VERSUS NEW WORLD - USA

ESPID Education, Samir S Shah, 20845

BLUE VERSUS RED - RECOMMENDATIONS ACROSS THE OCEAN

ESPID Education, Mike Sharland, 20846

INFANT IMMUNIZATION: STARTING FROM PREGNANCY

ESPID Education, Ener Dinleyici, 20839

ADDRESSING CONCERNS ABOUT VACCINES

ESPID Education, Gary S. Marshall, 20840

HOW PAEDIATRIC INFECTIOUS DISEASE SPECIALISTS MAY ASSIST INTERNISTS TO DEVELOP A LIFETIME VACCINATION SCHEDULE

ESPID Education, Ulrich Heininger, 20841

IMPROVING THE EVIDENCE BASE FOR ANTIBIOTIC USE IN EUROPE - WHAT DO WE DO AND WHY DO WE DO IT

ESPID Education, Nikos Spyridis, 20835

PROPOSED WAYS OF MEASUREMENT OF ANTIBIOTIC CONSUMPTION IN PAEDIATRIC HOSPITALS

ESPID Education, Herman Goossens, 20836

ECDC-PPS OF HEALTHCARE-ASSOCIATED INFECTIONS AND ANTIMICROBIAL USE IN ACUTE CARE HOSPITALS: EXAMPLES OF PAEDIATRIC AND NEONATAL RESULTS

ESPID Education, Carl Suetens, 20837

ANTIMICROBIAL STEWARDSHIP IN PAEDIATRIC HOSPITALS

ESPID Education, Theoklis Zaoutis, 20838

EPIDEMIOLOGY OF RESISTANT GRAM-POSITIVE BACTERIA

ESPID Education, Maria Koliou, 20831

EPIDEMIOLOGY OF RESISTANT AND PAN-RESISTANT GRAM-NEGATIVE BACTERIA

ESPID Education, George L. Daikos, 20832

MANAGEMENT OF INFECTIONS CAUSED BY RESISTANT (RB) AND PAN-RESISTANT BACTERIA (PRB) IN CHILDREN

ESPID Education, Robert Cohen, 20833

PREVENTION OF HORIZONTAL TRANSMISSION OF MICROBES: INFECTION CONTROL ISSUES IN THE HOSPITAL

ESPID Education, Walter Zingg, 20834

PROSPECTS FOR NOVEL TUBERCULOSIS VACCINES: WHERE DO WE STAND?

ESPID Education, Søren Tetens Hoff, 20828

PREVENTION AND TREATMENT OF TUBERCULOSIS IN IMMUNOCOMPROMISED CHILDREN

ESPID Education, Beate Kampmann, 20829

EPIDEMIOLOGY AND MANAGEMENT OF MULTIDRUG-RESISTANT AND EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS IN CHILDREN

ESPID Education, H. Simon Schaaf, 20830

NEWER ANTIBACTERIAL AGENTS FOR GRAM-POSITIVE INFECTIONS

ESPID Education, George Syrogiannopoulos, 20825

ANTIBACTERIAL AGENTS FOR RESISTANT GRAM NEGATIVE INFECTIONS (COLISTIN, TIGECYCLINE, FOSFOMYCIN)

ESPID Education, Charalampos Antachopoulos, 20826

NEW ANTIFUNGAL IN PEDIATRICS

ESPID Education, Adilia Warris, 20827

MICROBIOLOGY OF CYSTIC FIBROSIS

ESPID Education, Niels Hoeiby, 20821

FUNGAL PULMONARY SYNDROMES IN CYSTIC FIBROSIS

ESPID Education, Kris De Boeck, 20822

INHALED VERSUS INTRAVENOUS ANTIBIOTICS: PHARMACOKINETICS/PHARMACODYNAMICS ISSUES

ESPID Education, Roger Brüggemann, 20823

GBS AND THE NEONATE: PREVENTION STRATEGIES

ESPID Education, Pierrette Melin, 20815

LATE-ONSET INFECTIONS IN NICU

ESPID Education, Paul Heath, 20816

PREVENTION OF CANDIDA INFECTIONS IN NEONATES: DIFFERENT VIEWPOINTS - NEONATOLOGY

ESPID Education, Paolo Manzoni, 20817

PREVENTION OF CANDIDA INFECTIONS IN NEONATES: DIFFERENT VIEWPOINTS - MYCOLOGY

ESPID Education, J Peter Donnelly, 20818

LONG-TERM OUTCOMES OF CONGENITAL CYTOMEGALOVIRUS (CMV) INFECTION IN SWEDEN AND THE UNITED KINGDOM

ESPID Education, Claire Townsend, 20819

SCREENING FOR NOSOCOMIAL VIRAL INFECTIONS IN A NEONATAL INTENSIVE CARE UNIT

ESPID Education, Andre Kidszun, 20820

STRENGTHENING EUROPE´S DEFENCES AGAINST INFECTIOUS DISEASES OF THE YOUNG

ESPID Education, Giesecke Johan, 20812

PROTEOMICS AND GENOMICS - CAN THEY HELP US UNDERSTAND THE PATHOGENESIS OF INFECTIOUS DISEASES?

ESPID Education, Mike Levin, 20813

TRANSLATIONAL APPROACHES AND IMPLEMENTATION OF GUIDELINES IN PAEDIATRIC INFECTIOUS DISEASES

ESPID Education, Thomas Walsh, 20814

TUBERCULOSIS: FROM BENCH TO BEDSIDE

ESPID Education, Ben Marais, 8009

PNEUMOCOCCAL VACCINATION STRATEGIES: THE PUBLIC HEALTH PERSPECTIVE

ESPID Education, Kate O'Brien, 8008

Novel insights into the distribution of soil-transmitted helminthiasis and schistosomiasis using real-time PCR diagnosis

ESPID Education, Lisette Van Lieshout, 8007

IL-15 GENE POLYMORPHISMS ARE ASSOCIATED WITH RESISTANCE TO VISCERAL LEISHMANIASIS

ESPID Education, Manoochehr Rasouli, 8006

A NOVEL, FULLY AUTOMATED SAMPLE-TO-RESULT REAL-TIME PCR ASSAY FOR POINT-OF-CARE DETECTION OF DENGUE VIREMIA

ESPID Education, Steven Hatch, 8005

MALARIA AND SALMONELLA CO-INFECTION: A CONFLICT BETWEEN PATHOGEN TOLERANCE AND RESISTANCE

ESPID Education, Aubrey Cunnington, 8004

VISCERAL LEISHMANIASIS

ESPID Education, Shyam Sundar, 8003

CONTROL OF NEGLECTED TROPICAL DISEASES

ESPID Education, David Molyneux, 8002

IMPACT OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE ON INVASIVE PNEUMOCOCCAL DISEASE IN ALASKA NATIVE CHILDREN: RESULTS OF A CLINCAL TRIAL

ESPID Education, Rosalyln Singleton, 8086

THE EPIDEMIOLOGY OF INVASIVE MENINGOCOCCAL DISEASE IN EUROPE, 2008 AND 2009

ESPID Education, Ida Czumbel, 8087

PERTUSSIS RISK IN CHILDREN AS A FUNCTION OF TIME SINCE RECEIPT OF THE 5TH DOSE OF ACELLULAR PERTUSSIS VACCINE

ESPID Education, Nicola Klein, 8088

DEFINITION OF A CORRELATE OF PROTECTION FOR INACTIVATED INFLUENZA VACCINES IN CHILDREN LESS THAN FIVE YEARS OF AGE

ESPID Education, Steven Black, 8089

DETECTION OF MYCOPLASMA PNEUMONIAE IN HEALTHY CHILDREN BY REAL TIME PCR-PRELIMINARY DATA FROM THE MYMIC STUDY

ESPID Education, Emiel Spuesens, 8090

DETERMINING THE QUALITY OF CARE FOR ACUTE RESPIRATORY INFECTIONS IN MALAWIAN CHILDREN

ESPID Education, Erica Chapin, 8091

PAEDIATRIC ANTIBIOTIC USE IN THE NETHERLANDS BETWEEN 1996 AND 2010: AN ARPEC STUDY

ESPID Education, Sandra de Bie, 8093

MEASLES AND RUBELLA OUTBREAKS

ESPID Education, Rebecca Martin, 8001

SALMONELLA INFECTIONS IN DEVELOPING COUNTRIES

ESPID Education, Zulfiqar Bhutta, 8000

ANTIVIRAL THERAPY

ESPID Education, Hans L. Zaaijer, 7993

PHARMACOGENOMICS AND ANTIMICROBIAL AGENTS

ESPID Education, Andrew Owen, 7992

CONTINUING INCREASE IN 19A AND 6C SEROTYPE CARRIAGE IN CHILDREN AFTER THE INTRODUCTION OF PCV-7 IN THE NETHERLANDS

ESPID Education, S.M.P.J. Prevaes, 7709

SAFETY OF ADJUVANTED PANDEMIC INFLUENZA VACCINES: BACKGROUND RATE OF NARCOLEPSY IN EUROPE

ESPID Education, Jan Bonhoeffer, 7750

MOLECULAR DIAGNOSIS OF VIRAL INFECTIONS

ESPID Education, Martin Schutten, 7990

NEW DIAGNOSTIC METHODS FOR TUBERCULOSIS

ESPID Education, Nigel Curtis, 7989

MOLECULAR DIAGNOSIS OF INFECTIOUS DISEASES: QUO VADIS?

ESPID Education, Alex Van Belkum, 7988

HOW ACADEMIA AND INDUSTRY CAN CONTRIBUTE TO THE PROMISE OF CURRENT AND NEW VACCINES

ESPID Education, Sian Clayden, 7999

CLEAR AND ALIGNED COMMUNICATION IS VITAL TO REACH THE DESIRED OUTCOMES

ESPID Education, Joanne Yarwood, 7998

WHAT CAN WE LEARN FROM STRATEGIES THAT DO & DON'T WORK?

ESPID Education, Hanna Nohynek, 7997

IMMUNISATION PROGRAMMES: THE GLOBAL PERSPECTIVE

ESPID Education, Pierre Van Damme, 7995

VACCINATION POLICIES: THE EUROPEAN EXPERIENCE

ESPID Education, Kari Johansen, 7994

HIV/AIDS IN CHILDREN

ESPID Education, Diana Gibb, 7987

FROM IMMUNODEFICIENCIES TO INFECTIOUS DISEASES

ESPID Education, Alain Fischer, 7986

INHIBITING THE HOST FOR KILLING INTRACELLULAR PATHOGENS

ESPID Education, Jacques Neefjes, 7985

THE PARADOX OF GLOBAL HEALTH: SUCCESS, YET CRISIS

ESPID Education, Richard Horton, 7984